Qualigen Therapeutics's market cap is currently $2.67M. The company's EPS TTM is $-55.297; its P/E ratio is ―; Qualigen Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Mar 20
Income Statement
Total Revenue	$ 5.20M	$ 4.98M	$ 5.65M	$ 4.31M	$ 5.56M
Gross Profit	$ -4.50K	$ 680.80K	$ 1.32M	$ -2.88M	$ 1.58M
Operating Income	$ -11.30M	$ -17.94M	$ -22.66M	$ -11.30M	$ -1.50M
EBITDA	$ -11.30M	$ -13.84M	$ -22.66M	$ -11.16M	$ -10.02M
Net Income	$ -13.42M	$ -21.03M	$ -17.90M	$ -20.42M	$ -1.79M
Balance Sheet
Cash & Short-Term Investments	$ 401.80K	$ 7.03M	$ 17.54M	$ 23.98M	$ 153.12K
Total Assets	$ 2.03M	$ 19.08M	$ 22.84M	$ 29.13M	$ 3.72M
Total Debt	$ 1.30M	$ 2.71M	$ 1.68M	$ 375.56K	$ 2.22M
Net Debt	$ 897.41K	$ -4.33M	$ -15.86M	$ -23.60M	$ 2.07M
Total Liabilities	$ 4.14M	$ 10.32M	$ 6.27M	$ 10.83M	$ 5.65M
Stockholders' Equity	$ -2.10M	$ 7.24M	$ 16.56M	$ 18.29M	$ -1.93M
Cash Flow
Free Cash Flow	$ -10.30M	$ -13.57M	$ -14.87M	$ -9.97M	$ -137.15K
Operating Cash Flow	$ -10.30M	$ -13.25M	$ -14.73M	$ -9.76M	$ 57.33K
Investing Cash Flow	$ 4.22M	$ -183.76K	$ -141.36K	$ -160.56K	$ -194.48K
Financing Cash Flow	$ -550.00K	$ 2.91M	$ 8.43M	$ 33.76M	$ 165.14K

Currency in USD

Qualigen Therapeutics Earnings and Revenue History

Income Statement >

Qualigen Therapeutics Debt to Assets

Balance Sheet >

Qualigen Therapeutics Cash Flow

Cash Flow >

Qualigen Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing